Top 100 alternative sites to aptose.com
Kezar Life Sciences, Inc. (KZR)
Kezar Life Sciences is a clinical-stage biotechnology company committed to revolutionizing treatments for patients with autoimmune diseases and cancer.
I-Mab Biopharma | Bringing Transformational Medicines to Patients Through Innovation
I-Mab is a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of first-in-class and best-in-class biologics to treat cancers and autoimmune diseases.
Home - Abcuro
Development of immunotherapies for autoimmune diseases and cancer Read more about our approach in Fierce Biotech KLRG1 – A Compelling Clinical Target in Immune Modulation Abcuro is a clinical stage biotechnology company developing first-in-class immunotherapies for autoimmune diseases and cancer … Read More
Author: Abcuro
Clexio Biosciences Ltd.
Clexio Biosciences is a CNS-first clinical stage company. We are dedicated to developing novel drugs and technologies for patients suffering.
Marizyme, Inc. | Monetizing Life Science Assets
Cantex Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on developing and commercializing proprietary pharmaceuticals that improve the treatment of cancer and other life-threatening illnesses.
Targovax
Targovax (OSE:TRVX) is a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors.
Home | CellDrop Biosciences Inc
CellDrop Biosciences is a biotechnology company using microfluidics and hydrogel engineering to develop diagnostic and regenerative medicine products.
NĒRx BioSciences Inc | 212 W 10th Street, Indianapolis, IN 46202
NĒRx BioSciences Inc is a company dedicated to the discovery and development of targeted therapeutics for cancer. Formed in 2009, we specialize in the discovery and early development of novel biopharmaceutical compounds.
RadioMedix, Inc
RadioMedix, Inc. is a clinical stage biotechnology company, based in Houston, Texas, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer. The company is developing radiopharmaceuticals for PET imaging and therapeutic (alpha and beta-labeled) radiopharmaceuticals.
Home - Aura Biosciences
Aura Biosciences is pioneering a first-in-class technology to treat a wide variety of solid tumor types. We are initially pursuing cancers where patients are in need of a transformational change in treatment options, such as choroidal melanoma, so they can avoid choosing between preserving their life or their vision
IMV Inc.
IMV Inc. is a clinical-stage biopharmaceutical company developing a new class of cancer immunotherapies and vaccines against infectious diseases
Juventas Therapeutics
Juventas Therapeutics is a privately held biotechnology company developing a pipeline of regenerative therapies to treat life–threatening diseases.
Author: A M Design Group
Locus Biosciences | CRISPR-based precision medicine for the masses
Locus Biosciences is a biotechnology company that develops CRISPR-engineered precision antibacterial products.
Quincy Bioscience – The Makers of Prevagen
Quincy Bioscience is a biotechnology company focused on the discovery, development and commercialization of novel technologies to address cognitive issues.
OrphoMed Inc. | Gastrointestinal Disorders | Dimer Therapeutics Platform
OrphoMed is a clinical-stage biotechnology company with a proprietary dimer therapeutics platform. The company is focused on developing best-in class treatments for patients with gastrointestinal disorders.
PharmaCyte Biotech - Home of Biotechnology
PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes.
Precision radiopharmaceuticals | Precirix
PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments. The company is advancing its lead product CAM-H2 through a Phase I/II clinical trial targeting…
Home - Target BioScience AG
Are you looking for services to develop Pharmaceutical Business in Switzerland or Europe? Do you plan to register and launch Pharmaceuticals in Switzerland or Europe? Are you seeking Representation in Switzerland? Target BioScience is targeting pharmaceutical and biotechnology fields since 1993.
The BioScience Ventures Group
The BioScience Ventures Group - Venture capital Biotechnology Start-up -The BioScience Ventures Group (BSVG) is a venture capital firm focusing exclusively on life sciences. We offer pre-seed, seed and early stage financing. BSVG's approach to investments is
Author: The BioScience Ventures Group
Other sites like aptose com
ImmunoGen | Target a Better Now | ADC Technology-Focused Cancer Treatment
Target a better now with ImmunoGen, Inc., a biotechnology company focused on the development of antibody-**** conjugate (ADC) technology to treat cancer.
Prometheus Biosciences | A Different Kind of Biotech Company
Prometheus Biosciences is a biotechnology company specializing in developing precision therapies for autoimmune diseases using a one-of-a-kind approach.
MaaT Pharma - We restore microbiome function to treat life-threatening diseases
We are a clinical stage oncology company and industry leader in microbiome restoration therapy using biotherapeutics to treat life-threatening diseases.
Author: MaaT Pharma
THE NEXT REVOLUTIONIN CELL THERAPY
A clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCART™) therapies for cancer.
Ikena Oncology | Biomarker-Driven Cancer Therapeutics
Ikena Oncology is a clinical-stage biotechnology company that discovers and develops patient-directed, biomarker-driven therapies for cancer patients.
Author: Walid
Home - First Wave BioPharma, Inc.
First Wave BioPharma is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.
Home - Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Adicet Bio | Gamma Delta T cells
Adicet Bio, a pre-clinical stage biotechnology company engaged in the design and development of cutting-edge allogeneic immunotherapies for cancer and other diseases.
Summit Biosciences Inc.
Summit Biosciences is a pharmaceutical company developing, manufacturing and commercializing prescription and OTC medicines via nasal or sublingual sprays.
PEP-Therapy, Innovative peptides as targeted therapies for oncology
PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
SCYNEXIS, Inc. (SCYX)
SCYNEXIS is an innovative biotech company developing promising novel anti-infectives that target multiple life-threatening and serious indications.
Home - Pressure BioSciences Inc. - A Life Sciences Company
Pressure BioSciences is a life sciences company focused on the development and commercialization of a novel, enabling platform technology called Pressure Cycling Technology.
Prana Biosciences Inc.
PraNa Biosciences, Inc. is a specialty pharmaceutical company headquartered in Massachusetts focused on developing and commercializing value enhanced pharmaceutical products.
Home - Capsida
We are a biotechnology company creating a new class of targeted gene therapies for debilitating and life-threatening genetic disorders in both central nervous system (CNS) and non-CNS indications.
Celularity Inc. (NASDAQ:CELU)
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells (ASCs), targeting indications across cancer, immunologic, infectious, and degenerative diseases.
Author: Celularity Inc
Home - Pilz BioScience
Pilz Bioscience Corp. is a biotechnology company developing medicinal psychedelics for neuroinflammatory conditions with a significant cognitive component and high unmet needs, with a focus on Autism Spectrum Disorder (ASD).
Author: Dr Marvin S Hausman
Oncternal Therapeutics | Home
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. We’re committed to translate pioneering areas of cancer research into approved therapies that can be used to treat multiple cancer types.
Molecular Templates, Inc. (MTEM)
Molecular Templates is a clinical-stage biopharmaceutical company developing engineered toxin bodies (ETBs) for the treatment of cancers.
Tessa Therapeutics | Cancer Immunotherapy Treatments
Cure cancers with our innovative and widely accessible immunotherapies. Tessa Therapeutics is a clinical-stage biotechnology company focused on the development of autologous and allogeneic cell therapies for a broad range of cancers.
Home • Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease.
What else aptose.com alternative websites
Home - Bellicum Pharmaceuticals, Inc. : Bellicum Pharmaceuticals, Inc.
Bellicum is a clinical stage company focused on developing novel cellular immunotherapies for certain cancers and orphan inherited blood disorders.
Calithera | Targeting Cancer, Differently | Home
Calithera is developing first-in-class small molecule drugs directed against tumor metabolism and tumor immunology targets to treat cancer.
PanaceAR - The next generation theranostic platform | PanaceAR
COMPLETE DEBRIDEMENT FOR BURNS & DIABETIC ULCERS A next generation Biomarker for treating Life-Threatening Diseases TARGETING DIAGNOSIS & THERAPY IN CANCER A next generation Biomarker for treating Life-Threatening Diseases SPEEDING UP CARE & PROVING THERAPY A next generation Biomarker for treating Life-Threatening Diseases We bring innovation to multiple indications We have a robust pipeline of […]
Author: Juliette Bordet
Home - Amphera
Amphera B.V., a clinical stage Dutch life science company, develops dendritic cell therapies for the treatment of cancer.
Nasasbiotech – A new approach for fighting Cancer
Biotechnology company that develops novel clinical solutions to improve the diagnosis, prognosis and treatment of cancer.
Author: Nasasbiowp
Interpace Biosciences, Inc. (IDXG)
Interpace Diagnostics Group provides clinically useful molecular and related first line diagnostic tests for evaluating risk of cancer.
TVAX Biomedical, Inc.
TVAX Biomedical, Inc. is a biotechnology company currently performing phase II clinical trials to test a unique natural cancer immunotherapy as a treatment for brain cancer.
Scientific Solutions Without Compromise | TYME Inc
TYME Technologies Inc is an emerging biotechnology company focused on exploring novel therapeutic designed to target cancer’s unique metabolism.
Home | Avro Life Science
A clinical stage biotech redefining the skin’s potential as a target for novel first-in-class Therapies.
Adaptimmune Therapeutics plc
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients
Home - PTX Therapeutics
Prescient is an ASX-listed biotechnology company focused on improving outcomes for cancer patients by developing, licencing and collaborating on universal CAR-T therapies to treat a range of cancers.
Eledon Pharmaceuticals: Developing precision therapeutics that target the CD40 Ligand pathway
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing **** or cellular transplantation, and for people with autoimmune and neurodegenerative disease.
Home • Arvinas
Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins.
Home - Khondrion
Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease.
Cellestia, modulating gene expression
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus. The lead compound CB-103 has advanced to Phase 2 successfully treating patients with multi-**** resistant cancers.
Arcus Biosciences Home | Pursuit of Curing Cancer
Arcus is a biopharmaceutical company aiming to bring together scientists, physicians & advisors to focus on developing best-in-class cancer therapies.
Soricimed : Home
Soricimed Biopharma is a clinical stage **** development company dedicated to novel trageted treatments for cancer.
Home | Cellectis
Cellectis is a clinical-stage biopharmaceutical company developing the Next-Generation CAR T-Cells to Cure Cancer
mRNA Therapeutics for Genetic Disease | Translate Bio
Translate Bio is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat and prevent diseases caused by protein or gene dysfunction.
Spiral Therapeutics - Therapies for Hearing Loss
Spiral is a clinical stage pharmaceutical company developing therapies that target hearing loss and other ear disorders.
Other websites similar as aptose.com
Home - Celyad Oncology
ABOUT CELYAD ONCOLOGY Celyad Oncology is a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor
Author: Celyad Oncology
Celleron Therapeutics
Celleron is building a global oncology company focussed on the clinical development of new and innovative therapies to treat cancer.
Author: Paul Lacey
Beyond Air Inc. (XAIR)
Beyond Air is a clinical-stage medical device and biopharmaceutical company using nitric oxide to treat respiratory and other diseases.
PEG Biosciences
PEG Biosciences provides expertise and quality services in Pegylation to enhance efficacy and safety for your drugs. Our proprietary PEG-linkers and CRO services in Pegylation include custom synthesis for PEG-linker, **** development, analytical service, bio-conjugation, product scale-up, manufacturing, problem solving, regulatory submission, etc. We provide first-class services including consultancy for pharmaceutical companies to shorten development times for PEG-enhanced drugs.
Neurobehavioral Disorder **** Development | BlackThorn Therapeutics
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company developing novel, targeted treatments for neurobehavioral disorders. Learn more.
Caribou Biosciences | Developing Sophisticated Allogeneic Cell Therapies
Caribou is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for devastating human diseases.
Home | Da Volterra
Da Volterra is a clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiota field.Our mission is to discover, develop and bring to market safe and novel therapeutic options, preserving patients’ microbiota to prevent and cure life-threatening diseases.We strive to serve patients by transforming the promise of science into innovative treatments which have the power to improve health and save lives.
Oncology Therapeutics - Cardiff Oncology
Cardiff Oncology is a clinical-stage company with the singular mission of developing new oncology therapeutic options for cancer patients.
Home | Algiax Pharmaceuticals GmbH
News – Events About Us Algiax Pharmaceuticals is a clinical-stage biotechnology company established in 2011. It is dedicated to the discovery and development of innovative products to treat diseases with a high unmet medical need. Algiax’ lead candidate AP-325 is a small-molecule GABAA receptor modulator in clinical development as a therapy for neuropathic pain. Next […]
Home - Curis, Inc
About Curis is a biotechnology company focused on the development and commercialization of innovative therapeutics for the treatment of cancer. We currently have three **** candidates in development: Fimepinostat (formerly known as CUDC-907), an **** available, small molecule inhibitor of HDAC and PI3K enzymes being investigated in a Phase 2 clinical trial in patients with […]
Some websites with similar theme to aptose.com include:
Investor Relations :: The Coca-Cola Company (KO)
CLS Holdings USA, Inc. (CLSH)
Cannabis Life Sciences is both a cannabis producer and retailer offering a wide variety of products through its brands, Oasis and City Trees.
Texas Pacific Land Corporation (TPL)
Texas Pacific Land Trust is one of the largest landowners in the State of Texas with approximately 900,000 acres of land in West Texas.
W&T Offshore, Inc.
W&T Offshore, Inc. is an independent oil and natural gas producer, exploring, developing, and acquiring oil and natural gas in the Gulf of Mexico.
Trevena, Inc. (TRVN)
Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System conditions.
Basic Energy Services, Inc.
Basic Energy Services offers a diverse number of services to oil drilling and natural gas producing companies in the U.S.
Lightbridge Corporation (LTBR)
Lightbridge Corporation is a nuclear fuel technology development company focused on addressing the world’s climate and energy needs.
Sonnet BioTherapeutics, Inc. (SONN)
Sonnet BioTherapeutics is taking the fight directly to cancer using its proprietary FHAB™ technology to empower innovative targeted biologic drugs.
Northern Oil and Gas, Inc. (NOG)
Northern Oil and Gas, Inc. (NYSE MKT: NOG) is the leading non-operated working interest franchise in the premier shale basins across the United States. The foundation of the Company's success is the long-term relationships it has built in basin…
Matthews International Corporation (MATW)
Matthews International Corporation is a global provider of brand solutions, memorialization products and industrial technologies.
More other alternatives for aptose com
BioXcel Therapeutics, Inc. (BTAI)
BioXcel Therapeutics is developing high value therapeutics in neuroscience and immuno-oncology utilizing a novel artificial intelligence platform.
Processa Pharmaceuticals, Inc. (PCSA)
Processa Pharmaceuticals is committed to developing **** products aimed at improving the quality of life for patients with unmet medical needs.
幸运飞艇最新开奖结果查询-实时开奖直播视频-新版飞鹰计划 Norwegian Cruise Line Holdings Ltd. (NCLH)
btcc经贸环球交易所_比特币global交易软件_BTCC官网
Texas Pacific Land Trust is one of the largest landowners in the State of Texas with approximately 900,000 acres of land in West Texas.
Investor Relations :: TopBuild Corp. (BLD)
TopBuild Corp., headquartered in Daytona Beach, Florida, is a leading installer and specialty distributor of insulation and building material products to the North American construction industry. We provide insulation solutions and building…
Fortress Biotech, Inc. (FBIO)
Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company that was ranked in Deloitte’s 2019 and 2020 Technology Fast 500™, annual rankings of the fastest-growing North American companies in the technology,…
Macy's, Inc.
Macy’s, Inc. is one of the nation’s premier omnichannel retailers. Headquartered in New York City, the company comprises three retail brands: Macy’s, Bloomingdale’s and Bluemercury. With a robust e-commerce business, rich mobile experience and a national stores footprint, our customers can shop the way they live — anytime and through any channel.
Freedom Holding Corp. (FRHC)
Freedom Holding is a US-based corporation that owns several operating subsidiaries that engage in the securities industry in Central Asia.
DiaMedica Therapeutics, Inc. (DMAC)
DiaMedica Therapeutics is a biopharmaceutical company that specializes in creating synthetic proteins to treat a variety of conditions.
Bristow Group Inc. (VTOL)
Bristow provides safe, reliable and efficient helicopter services for offshore oil and gas transportation, SAR and government and civil organizations.
VF Corporation (VFC)
VF Corporation outfits consumers around the world with its diverse portfolio of iconic outdoor and activity-based lifestyle and workwear brands.
New Residential Investment Corp. (NRZ)
New Residential is a publicly traded mortgage real estate investment trust with a diversified portfolio and a strong track record of performance.
Helios Technologies (HLIO)
Helios Technologies (formerly Sun Hydraulics Corporation) is a global industrial technology leader that develops and manufactures hydraulic and electronic control solutions for diverse markets.
Delta Apparel, Inc. (DLA)
Investor Relations :: Norwegian Cruise Line Holdings Ltd. (NCLH)
Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) is a leading global cruise company which operates the Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands. With a combined fleet of 28 ships with approximately 59,150…
OPKO Health, Inc. (OPK)
OPKO Health is a diverse healthcare company focused on improving patient lives.
Medexus Pharmaceuticals, Inc. (MDP)
Baudax Bio, Inc. (BXRX)
Baudax Bio is a specialty pharmaceutical company focused on products for hospitals and ambulatory care settings.
Riot Blockchain, Inc. (RIOT)
Investor Relations
Arko is a holding company which owns 100% of GPM Investments, LLC (“GPM”). Based in Richmond, VA, GPM was founded in 2003 with 169 stores and has grown through acquisitions to become the 7th largest convenience store chain in the…
Investor Relations
PARTS iD, Inc. is a technology-driven, digital commerce company focused on creating custom infrastructure and unique user experiences within niche markets. PARTS iD was originally founded in 2008 as Onyx Enterprises, Int’l, Corp. Its vision was…